Nexpring Health, a global leader in assisted reproductive technology (ART) solutions, today announced a strategic investment in May Health, a medical device company pioneering a novel treatment ...
The MarketWatch News Department was not involved in the creation of this content. OTTAWA, ON, Oct. 16, 2025 /CNW/ - The Survivors Circle for Reproductive Justice and the University of Ottawa Centre ...
In the quest to address infertility, Cornell researchers have developed a groundbreaking device that could simplify and automate oocyte cumulus removal, a critical step in assisted reproductive ...
The global Assisted Reproductive Technology (ART) market is poised for significant growth, with a value of USD 29.59 billion in 2025, projected to reach USD 49.30 billion by 2033 at a 6.59% CAGR. Key ...
BOSTON, Dec. 3, 2025 /PRNewswire/ -- Granata Bio Corporation, a biotechnology company advancing innovative reproductive health solutions, announced strong momentum in its pivotal Phase III clinical ...
Consistency in Care and Improved Engagement: Patients benefit from advanced laboratory innovation without added complexity or changes to their care pathway. Patients can receive a video record of ...
Findings show significant risk for asthma, allergic rhinitis, or atopic dermatitis. HealthDay News — Children conceived via assisted reproductive technology (ART) have a higher risk for developing ...
IVF treatment does not appear to increase long-term risks of major cardiovascular disease or breast cancer, although outcomes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results